Evidence map

ReviewBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2022

Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir.

Paul Andrei Negru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35131656